Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer.
Bleve S, Cursano MC, Casadei C, Schepisi G, Menna C, Urbini M, Gianni C, De Padova S, Filograna A, Gallà V, Rosti G, Barone D, Chovanec M, Mego M, De Giorgi U. Bleve S, et al. Among authors: rosti g. Front Oncol. 2022 Jun 10;12:910087. doi: 10.3389/fonc.2022.910087. eCollection 2022. Front Oncol. 2022. PMID: 35756636 Free PMC article. Review.
High-dose chemotherapy in adult patients with germ cell tumors.
De Giorgi U, Papiani G, Severini G, Fiorentini G, Marangolo M, Rosti G. De Giorgi U, et al. Among authors: rosti g. Cancer Control. 2003 Jan-Feb;10(1):48-56. doi: 10.1177/107327480301000106. Cancer Control. 2003. PMID: 12598855 Free article. Review.
Prevention and therapy of neutropenia in elderly patients.
Rosti G, Kopf B, Cariello A, Monti M, Dazzi C, Papiani G, Giovanis P, De Giorgi U, Marangolo M. Rosti G, et al. Crit Rev Oncol Hematol. 2003 Jun;46(3):247-53. doi: 10.1016/s1040-8428(03)00024-6. Crit Rev Oncol Hematol. 2003. PMID: 12791424 Review.
High dose chemotherapy in germ cell tumors.
Rosti G, De Giorgi U. Rosti G, et al. Tunis Med. 2005 Dec;83 Suppl 12:85-6. Tunis Med. 2005. PMID: 16430076 Review. No abstract available.
Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer.
De Giorgi U, Giannini M, Frassineti L, Kopf B, Palazzi S, Giovannini N, Zumaglini F, Rosti G, Emiliani E, Marangolo M. De Giorgi U, et al. Among authors: rosti g. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1165-9. doi: 10.1016/j.ijrobp.2006.02.018. Epub 2006 May 6. Int J Radiat Oncol Biol Phys. 2006. PMID: 16682141 Clinical Trial.
474 results